Omada Health Inc (OMDA) PT Lowered to $18 at BMO Capital

BMO Capital analyst Sean Dodge lowered the price target on Omada Health Inc (NASDAQ: OMDA) to $18.00 (from $27.00) while maintaining an Outperform rating.

The analyst commented: "Q4 revenue and EBITDA beat consensus by $3.6M (5.2%) and $5.0M, respectively, after adjusting for a 1x $2M benefit to both. Initial '26 guidance was also ahead of consensus as momentum continues across GLP-1s, but importantly also across its prevention-based solutions (e.g, diabetes, hypertension). Moreover, the outlook also includes several pockets of conservatism that could drive upside via execution. While valuation remains under pressure across the broader HCIT landscape—and we lower our target price as a result—we are encouraged by today's update and growth runway ahead."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• AI/ML Innovations plans $2M private placement on the CSE